Bluebird Bio Inc (BLUE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

60 BINNEY STREET CAMBRIDGE, MA 02142

Bluebird Bio, Inc., a clinical-stage biotechnology company, focuses on the development, manufacture, and marketing of therapies to treat various human diseases.

Data as of 2020-08-01
Market Cap3.378 Billion Shares Outstanding55.652 Million Avg 30-day Volume959.494 Thousand
P/E Ratio Dividend Yield EPS-14.96
Price/Sales82.857 Price cash flow ratio5.7 Price free cash flow ratio-6.5
Book Value20.13 Price to Tangible Book3.12 Alpha-0.02
Short Interest Ratio % Short Interest to Float R-squared0.299853
BETA2.30776 52-week High/Low127.0 / 38.95 Stddev0.181324

Are you looking for these stocks instead?

View SEC Filings from BLUE instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 1 1 (0.07%)
13F Filers holding this stock: 240 56 (3.67%)
Aggregate 13F shares on 03/31/2020: 57.582 Million 23.796 Million
Aggregate 13F shares on 12/31/2019: 60.037 Million 24.023 Million
Percent change: -4.09% -0.95%
Funds creating new positions: 30 7
Funds Adding to an existing position: 95 24
Funds closing out their position: 57 24
Funds reducing their position: 75 15
Heat Map Ranking for 03/31/2020 280
Heat Map Ranking for 12/31/2019 222
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BLUE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BLUE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

1.3 Thousand total shares from 7 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HEDLEY MARY LYNNE

  • Director
1,136 2020-07-23 0

WENTWORTH KORY JAMES PRINCIPAL ACCOUNTING OFFICER

9,594 2020-07-20 5

DAVIDSON DAVID CHIEF MEDICAL OFFICER

39,850 2020-07-02 7

LESCHLY NICK PRESIDENT AND CEO

268,603 2020-07-02 5

COLE JASON CHIEF OPERATING AND

  • LEGAL OFFICER
35,410 2020-07-02 5

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

36,101 2020-07-02 13

FINGER ALISON CECILY CHIEF COMMERCIAL OFFICER

27,133 2020-07-02 6

SMITH-FARRELL JOANNE CHIEF BUSINESS OFFICER

22,349 2020-07-02 8

DIXON WENDY L

  • Director
14,243 2020-06-30 1

TEPPER ROBERT I

  • Director
  • 10% Owner
0 2020-06-26 0

LYNCH DANIEL

  • Director
127,904 2020-06-24 1

SCHENKEIN DAVID P

6,832 2020-06-18 1

VACHON MARK

3,657 2020-06-18 1

AGWUNOBI JOHN O

6,324 2020-06-18 1

MELTON DOUGLAS

6,324 2020-06-18 1

SELLERS WILLIAM R.

3,612 2020-06-18 3

BAIN LINDA

  • Director
0 2020-06-10 0

GILLIS STEVEN

  • Director
0 2020-06-10 0

MARAGANORE JOHN

  • Director
30,172 2020-05-28 0

BAIRD WILLIAM D III

  • Director
0 2020-05-20 2

WALSH JEFFREY T. CHIEF STRATEGY OFFICER

  • Officer
40,921 2019-08-20 1

FINER MITCHELL H.

  • Director
0 2019-07-31 0

ARCH VENTURE FUND VII, L.P.

ARCH VENTURE PARTNERS VII, L.P.

ARCH VENTURE PARTNERS VII, LLC

CRANDELL KEITH

BYBEE CLINTON

NELSEN ROBERT

  • 10% Owner
4,242,051 2019-07-15 0

HIGH SUSANNA GATTI CHIEF OPERATING OFFICER

  • Officer
13,735 2018-12-06 0

MANDELL JAMES

  • Director
1,000 2018-09-10 0

SULLIVAN ERIC PRINCIPAL ACCOUNTING OFFICER

  • Officer
5,974 2017-08-03 0

DETORE JAMES M. SEE REMARKS

  • Officer
0 2016-08-04 0

THIRD ROCK VENTURES LP

THIRD ROCK VENTURES GP, L.P.

TRV GP, LLC

  • 10% Owner
No longer subject to file 2015-04-07 0

TVM V LIFE SCIENCE VENTURES GMBH & CO KG

TVM CAPITAL GMBH

POLACK AXEL

SCHUHSLER HELMUT

GOLL ALEXANDRA

BIRNER HUBERT

FISCHER STEFAN

  • 10% Owner
2,254,357 2013-06-24 0

MULDER GEERT-JAN

  • Director
No longer subject to file 2013-06-24 0

POLACK AXEL

  • Director
2,254,357 2013-06-24 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

WENTWORTH KORY JAMES PRINCIPAL ACCOUNTING OFFICER

2020-07-20 S 596 $66.38 d 9,594 9,594.00 direct yes

LESCHLY NICK PRESIDENT AND CEO

2020-07-02 S 443 $61.57 d 99,904 268,603.00 direct

COLE JASON CHIEF OPERATING AND LEGAL OFFICER

2020-07-02 S 38 $61.57 d 35,410 35,410.00 direct

DAVIDSON DAVID CHIEF MEDICAL OFFICER

2020-07-02 S 42 $61.57 d 39,850 39,850.00 direct

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

2020-07-02 S 59 $61.57 d 36,101 36,101.00 direct

SMITH-FARRELL JOANNE CHIEF BUSINESS OFFICER

2020-07-02 S 38 $61.57 d 22,349 22,349.00 direct

FINGER ALISON CECILY CHIEF COMMERCIAL OFFICER

2020-07-02 S 36 $61.57 d 27,133 27,133.00 direct

VACHON MARK

2020-06-18 A 157 a 2,157 3,657.00 direct

AGWUNOBI JOHN O

2020-06-18 A 3,000 a 3,000 6,324.00 direct

DIXON WENDY L

2020-06-18 A 3,000 a 3,000 5,653.00 direct

MELTON DOUGLAS

2020-06-18 A 3,000 a 3,000 6,324.00 direct

LYNCH DANIEL

2020-06-18 A 4,200 a 4,200 7,959.00 direct

SCHENKEIN DAVID P

2020-06-18 A 3,000 a 3,000 6,832.00 direct

SELLERS WILLIAM R.

2020-06-18 A 3,000 a 3,000 3,612.00 direct

VACHON MARK

2020-06-18 A 3,000 a 3,000 3,657.00 direct

AGWUNOBI JOHN O

2020-06-18 A 1,500 a 6,324 6,324.00 direct

DIXON WENDY L

2020-06-18 A 1,500 a 5,653 5,653.00 direct

MELTON DOUGLAS

2020-06-18 A 1,500 a 6,324 6,324.00 direct

LYNCH DANIEL

2020-06-18 A 2,100 a 7,959 7,959.00 direct

SCHENKEIN DAVID P

2020-06-18 A 1,500 a 6,832 6,832.00 direct

SELLERS WILLIAM R.

2020-06-18 A 1,500 a 3,612 3,612.00 direct

VACHON MARK

2020-06-18 A 1,500 a 3,657 3,657.00 direct

AGWUNOBI JOHN O

2020-06-18 A 124 a 4,824 6,324.00 direct

DIXON WENDY L

2020-06-18 A 153 a 4,153 5,653.00 direct

MELTON DOUGLAS

2020-06-18 A 124 a 4,824 6,324.00 direct

LYNCH DANIEL

2020-06-18 A 259 a 5,859 7,959.00 direct

SCHENKEIN DAVID P

2020-06-18 A 156 a 5,332 6,832.00 direct

SELLERS WILLIAM R.

2020-06-18 A 112 a 2,112 3,612.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments